LPL Financial
PBE icon

LPL Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

LPL Financial’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.87M Sell
86,740
-10,564
-11% -$854K ﹤0.01% 2352
2025
Q4 		$7.99M Buy
97,304
+4,617
+5% +$357K ﹤0.01% 2120
2025
Q3 		$6.48M Buy
92,687
+15,792
+21% +$1.07M ﹤0.01% 2247
2025
Q2 		$4.93M Sell
76,895
-5,869
-7% -$364K ﹤0.01% 2322
2025
Q1 		$5.25M Sell
82,764
-9,341
-10% -$629K ﹤0.01% 2110
2024
Q4 		$6.13M Buy
92,105
+1,503
+2% +$104K ﹤0.01% 1906
2024
Q3 		$6.33M Sell
90,602
-10,157
-10% -$703K ﹤0.01% 1797
2024
Q2 		$6.53M Buy
100,759
+3,693
+4% +$234K ﹤0.01% 1656
2024
Q1 		$6.28M Buy
97,066
+14,003
+17% +$911K ﹤0.01% 1624
2023
Q4 		$5.47M Buy
83,063
+32,972
+66% +$1.92M ﹤0.01% 1632
2023
Q3 		$2.86M Sell
50,091
-2,936
-6% -$179K ﹤0.01% 2003
2023
Q2 		$3.25M Sell
53,027
-5,691
-10% -$355K ﹤0.01% 1855
2023
Q1 		$3.69M Buy
58,718
+14,840
+34% +$956K ﹤0.01% 1700
2022
Q4 		$2.79M Buy
43,878
+1,261
+3% +$80K ﹤0.01% 1825
2022
Q3 		$2.51M Buy
42,617
+13,399
+46% +$826K ﹤0.01% 1811
2022
Q2 		$1.69M Sell
29,218
-3,435
-11% -$198K ﹤0.01% 2159
2022
Q1 		$2.02M Sell
32,653
-8,543
-21% -$521K ﹤0.01% 2053
2021
Q4 		$2.93M Buy
41,196
+677
+2% +$49K ﹤0.01% 1811
2021
Q3 		$3.03M Buy
40,519
+2,136
+6% +$163K ﹤0.01% 1736
2021
Q2 		$2.97M Buy
38,383
+3,360
+10% +$250K ﹤0.01% 1691
2021
Q1 		$2.58M Sell
35,023
-270
-0.8% -$20.4K ﹤0.01% 1654
2020
Q4 		$2.48M Buy
35,293
+1,712
+5% +$108K ﹤0.01% 1533
2020
Q3 		$1.9M Buy
33,581
+9,653
+40% +$567K ﹤0.01% 1493
2020
Q2 		$1.39M Buy
23,928
+1,299
+6% +$70.8K ﹤0.01% 1587
2020
Q1 		$1.05M Buy
22,629
+1,356
+6% +$70.7K ﹤0.01% 1582
2019
Q4 		$1.19M Sell
21,273
-1,508
-7% -$78.6K ﹤0.01% 1707
2019
Q3 		$1.08M Sell
22,781
-5,678
-20% -$291K ﹤0.01% 1679
2019
Q2 		$1.52M Sell
28,459
-8,916
-24% -$463K ﹤0.01% 1418
2019
Q1 		$2.06M Sell
37,375
-157
-0.4% -$8.3K ﹤0.01% 1178
2018
Q4 		$1.77M Sell
37,532
-1,655
-4% -$85.1K ﹤0.01% 1139
2018
Q3 		$2.33M Sell
39,187
-286
-0.7% -$16.7K 0.01% 1081
2018
Q2 		$2.16M Buy
39,473
+578
+1% +$29.4K 0.01% 1089
2018
Q1 		$1.91M Sell
38,895
-3,164
-8% -$161K 0.01% 1139
2017
Q4 		$1.98M Buy
42,059
+34
+0.1% +$1.59K 0.01% 1058
2017
Q3 		$2.1M Buy
42,025
+58
+0.1% +$2.75K 0.01% 965
2017
Q2 		$1.92M Sell
41,967
-9,420
-18% -$407K 0.01% 961
2017
Q1 		$2.15M Sell
51,387
-1,888
-4% -$79.1K 0.01% 796
2016
Q4 		$2.1M Sell
53,275
-5,856
-10% -$236K 0.02% 772
2016
Q3 		$2.48M Sell
59,131
-2,758
-4% -$113K 0.02% 659
2016
Q2 		$2.38M Sell
61,889
-82,434
-57% -$3.23M 0.02% 676
2016
Q1 		$5.71M Sell
144,323
-35,053
-20% -$1.36M 0.02% 654
2015
Q4 		$8.68M Buy
179,376
+88,740
+98% +$4.38M 0.02% 492
2015
Q3 		$4.36M Sell
90,636
-7,448
-8% -$416K 0.02% 513
2015
Q2 		$5.72M Buy
98,084
+11,707
+14% +$669K 0.03% 463
2015
Q1 		$4.79M Buy
86,377
+11,794
+16% +$638K 0.02% 534
2014
Q4 		$3.74M Buy
74,583
+12,090
+19% +$592K 0.02% 606
2014
Q3 		$2.87M Buy
62,493
+718
+1% +$32.3K 0.02% 687
2014
Q2 		$2.7M Sell
61,775
-29,222
-32% -$1.18M 0.02% 724
2014
Q1 		$3.79M Buy
90,997
+6,207
+7% +$266K 0.02% 541
2013
Q4 		$3.14M Buy
84,790
+13,699
+19% +$491K 0.02% 614
2013
Q3 		$2.45M Buy
71,091
+27,470
+63% +$910K 0.02% 680
2013
Q2 		$1.26M Buy
+43,621
New +$1.24M 0.01% 972

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

LPL Financial's PBE Position: Q1 2026 in Review

LPL Financial reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 11% in Q1 2026, selling an estimated $854K and leaving 86,740 shares worth $6.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

LPL Financial first reported a position in PBE in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.68M in Q4 2015. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • LPL Financial held 86,740 shares of Invesco Biotechnology & Genome ETF worth $6.87M as of Q1 2026.
  • LPL Financial sold 10,564 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $854K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #2352 holding.
  • LPL Financial first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's Invesco Biotechnology & Genome ETF position peaked at $8.68M in Q4 2015.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.